Common Antidepressant Shows Promise for Long COVID Fatigue in Clinical Trial
A randomized clinical trial involving 399 adults has found that the inexpensive antidepressant fluvoxamine may help address one of the most disabling symptoms of long COVID: crushing fatigue.
The study, which compared fluvoxamine against a placebo, demonstrated that patients receiving the antidepressant experienced significant reductions in fatigue levels alongside improvements